Here's What Key Metrics Tell Us About Alignment Healthcare (ALHC) Q3 Earnings

Zacks
Zacksで開く
Here's What Key Metrics Tell Us About Alignment Healthcare (ALHC) Q3 Earnings

Alignment Healthcare (ALHC) reported $1.36 billion in revenue for the quarter ended September 2026, representing a year-over-year increase of 36.7%. EPS of -$0.04 for the same period compares to $0.02 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.31 billion, representing a surprise of +3.63%. The company has not delivered EPS surprise, with the consensus EPS estimate being -$0.04.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Alignment Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Medical benefits ratio: 89.5% versus the four-analyst average estimate of 88.9%. Health Plan Membership - Ending: 301,200 versus 297,053 estimated by four analysts on average. Revenues- Other: $10.03 million compared to the $9 million average estimate based on two analysts. The reported number represents a change of +0.2% year over year. Revenues- Earned premiums: $1.35 billion versus $1.3 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +37.1% change.

View all Key Company Metrics for Alignment Healthcare here>>>

Shares of Alignment Healthcare have returned +0.3% over the past month versus the Zacks S&P 500 composite's +0.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Alignment Healthcare, Inc. (ALHC): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research